Member Directory

Rhythm Biosciences Limited

Member Contact: David Atkins

Position: Chief Executive officer

Industry: Medtech & Digital

Company Profile:

Rhythm Biosciences (ASX:RHY) is an innovative Australian, publicly listed medical diagnostics company, with a focus on delivering simple, affordable blood tests for the accurate detection of cancers, providing physicians with accurate and reliable diagnostic tools.

Early detection is critical to improving patient outcomes and reducing the global burden of cancer.

ColoSTAT®, Rhythm Bioscience’s first simple blood-based cancer test, designed for the early detection of colorectal cancer, is an alternative screening test for individuals unable to or are unwilling to use currently available screening modalities. The test is being updated to meet the IVDR (In vitro diagnostic medical devices regulation) regulatory standards.

Rhythm Biosciences is committed to working with likeminded global partners to achieve commercialisation and distribution of these simple solutions.

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.